 |
 |

Drug Monitoring of Surgical Patients
David A. Danielson, MS;
Jane B. Porter, MS;
Barbara J. Dinan, RN;
Patrick C. O'Connor, MB, MRCP, PhD;
David H. Lawson, MD, FRCP;
Gavin S. M. Kellaway, MD;
Hershel Jick, MD
JAMA. 1982;248(12):1482-1485.
Abstract
Intensive drug monitoring of surgical patients was carried out on selected wards in five hospitals in the United States, Scotland, and New Zealand from 1977 through 1981. This report describes the methods and some findings from the monitoring of 5,232 such patients. Patients received, on the average, nine drugs on the ward, and adverse reactions were associated with 2.2% of these drug orders. Of the 1,150 drug-attributed adverse reactions, only 62 were considered "major" by the attending physician, and 35 (affecting 20 patients) were termed "life threatening." There were no drug-attributed deaths.
(JAMA 1982;248:1482-1485)
Author Affiliations
From the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Waltham, Mass.
Footnotes
Reprint requests to Boston Collaborative Drug Surveillance Program, 400-1 Totten Pond Rd, Waltham, MA 02154 (Dr Jick).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Drug-Induced Cutaneous Reactions: A Report From the Boston Collaborative Drug Surveillance Program on 15 438 Consecutive Inpatients, 1975 to 1982
Bigby et al.
JAMA 1986;256:3358-3363.
ABSTRACT
Intensive Hospital Monitoring Study of Intravenous Cimetidine
Porter et al.
Arch Intern Med 1986;146:2237-2239.
ABSTRACT
Adverse Tissue Reactions to Drugs: a Five-year Surveillance Study
Mikhael and Kacew
Hum Exp Toxicol 1985;4:583-590.
ABSTRACT
Monitoring of Adverse Drug Reactions by means of Autopsy Tissue Examination
Mikhael and Kacew
Hum Exp Toxicol 1984;3:133-140.
ABSTRACT
|